细胞技术研发
Search documents
松潘华松紫贝生物科技有限公司成立,注册资本6000万人民币
Sou Hu Cai Jing· 2026-02-10 01:14
Company Overview - Songpan Huason Purple Shell Biotechnology Co., Ltd. has been established with a registered capital of 60 million RMB [1] - The legal representative is Liu Yangya, and the shareholders include Sichuan Xingcan Huaxiao Bei Biotechnology Co., Ltd. (51%) and Songpan County State-owned Assets Investment Management Co., Ltd. (49%) [1] Business Scope - The company engages in agricultural scientific research and experimental development, cell technology research and application, and various technical services including consulting and technology transfer [1] - Other activities include the cultivation and acquisition of traditional Chinese medicine, ecological environment material sales, and the development of composite microbial fertilizers and biopesticides [1] - The company also focuses on smart agricultural management, industrial internet data services, and crop pest control services [1] Regulatory Information - The company is registered under the category of scientific research and technical services, specifically in engineering and technology research and experimental development [1] - It is located in Songpan County, Aba Tibetan and Qiang Autonomous Prefecture, Sichuan Province, with an operational period until February 9, 2026, and no fixed term thereafter [1] - The business activities are subject to approval by relevant authorities, particularly for projects involving national key protected wild plants [1]
金河生物成立新公司,含细胞技术研发业务
Zheng Quan Shi Bao Wang· 2025-08-18 07:25
Core Insights - A new company, Jinhe Aichongyi (Shanghai) Biotechnology Co., Ltd., has been established with a registered capital of 10 million yuan [1] - The company's business scope includes medical research and experimental development, cell technology research and application, and internet information services for pharmaceuticals [1] - Jinhe Aichongyi is wholly owned by Jinhe Biology (002688) [1]